DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Triesence (Triamcinolone Ophthalmic) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Triesence (Triamcinolone Ophthalmic) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (5)

Reports by Reaction Type

Cataract Nuclear (2)Intraocular Pressure Increased (2)Off Label Use (2)Condition Aggravated (2)Ocular Hypertension (2)Endophthalmitis (1)Fungal Test Positive (1)

Possible Triesence side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Intraocular Pressure Increased, Ocular Hypertension

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 4 mg qd subconjunctival

Gentamicin
    Dosage: 20 mg qd subconjunctival

Triesence
    Dosage: 4 mg total intraocular
    Indication: Prophylaxis



Possible Triesence side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Intraocular Pressure Increased, Ocular Hypertension

Drug(s) suspected as cause:
Dexamethasone (None)
    Dosage: (4 mg qd subconjunctival)

Gentamicin (None)
    Dosage: (20 mg qd subconjunctival)

Triesence
    Dosage: (4 mg total intraocular)
    Indication: Prophylaxis



Possible Triesence side effects in

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-28

Patient:

Reactions: Cataract Nuclear, Off Label Use, Condition Aggravated

Drug(s) suspected as cause:
Bevacizumab
    Dosage: unspecified unit, unspecified interval
    Indication: AGE-Related Macular Degeneration

Triesence
    Dosage: unspecified unit, unspecified interval
    Indication: AGE-Related Macular Degeneration



Possible Triesence side effects in

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-28

Patient:

Reactions: Cataract Nuclear, Off Label Use, Condition Aggravated

Drug(s) suspected as cause:
Bevacizumab: / Bevacizuamb
    Dosage: intraocular
    Indication: AGE-Related Macular Degeneration

Triesence
    Dosage: intraocular
    Indication: AGE-Related Macular Degeneration



Possible Triesence side effects in

Reported by a physician from Australia on 2012-06-25

Patient:

Reactions: Endophthalmitis, Fungal Test Positive

Drug(s) suspected as cause:
Triesence

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012